GNPDA1 and hepatocellular carcinoma: As mentioned before, GNPDA1 displayed a pro-tumor effect in HCC, and we would expect that, by exposing cancer cells to an anti-tumor drug, the expression/activity of GNPDA1 would be down-regulated.